For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

Hamilton Health Sciences is issuing a reminder that vaccines for respiratory syncytial virus are available for infants less than a year old after seeing a rise in cases over the holiday season.

Texas Department of State Health Services data showed less than 50 HMPV-positive cases each week in December across the state ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.